Radiotherapy or radiation therapy has been a key pillar of the palliative and curative care for cancer patients. The market has been a key enabler as well an accelerator for oncologic care world over. Advent of state-of-the-art instrumentation has remarkably improved the delivery technique. Progress made in understanding of radiobiology has enabled oncologists improve the effectiveness of radiotherapy in eradicating tumor cells. A growing body of studies have shed light on tumor microenvironments, hence paved way to new target discoveries for radiotherapy market. Recently, radiotherapy when combined with immunocheckpoint blockade has improved the targeting of metastatic tumors in patient population. More notably, radiotherapy has benefited more when combined with other therapies.
Advances in radio-oncogenomic and radiation-immunotherapeutic approaches have propelled strides in the radiotherapy market. The growing clinical potential of radiotherapy in curative treatment modalities in Western countries has expanded the market avenue over the years. Advances in imaging systems have radiation therapies have improved the efficacy as image-guided radiation therapy are more precise and have less side-effects.
Over the years, companies have been focused on developing radio-therapeutic devices that can be used in the treatment of cancers in deep tissues. Expanding use of these devices in therapeutics is boosting the market. Growing clinical avenue in the treatment of melanoma skin cancers (NMSC) is expanding the horizon of the radiotherapy market. Most prominently, there is a widespread demand for therapies for reducing the prevalence of basal cell carcinoma (BCC), a very common skin cancer.
Geographically, some of the key regional markets are North America, Europe, and Asia Pacific. Healthcare industry in the developing and developed regions of the aforementioned regions are seeing large revenue potential of better therapies for the management of cancer. The clinical potential of radiotherapy in improving tumor elimination is boosting the prospects. Countries such as the U.S. and the U.K. are witnessing extensive study on radiation-induced cellular responses in cancer cells, unlocking new prospects in the overall radiotherapy market.
Interested in this report?
Get a FREE Brochure now!
*Get Brochure (PDF) sent to your email within minutes
Get a free copy if the report you purchased is updated within 90 days